Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00873288 · ClinicalTrials.gov registry record · NA

Activating Collaborative CIS Support Via Targeted Provider Mailing

A NA study, sponsored by Northwestern University.

Completed
Registry status
NA
Development phase
254
Enrollment target

NCT00873288 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 254 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00873288, a NA study, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
NA
Development phase
254 participants
Enrollment target

Study Summary

RATIONALE: Receiving a reminder letter from their doctor with questions to ask the Cancer Information Service may be more effective than a standard reminder letter in helping patients who have had an abnormal Pap test keep their follow-up colposcopy appointment. PURPOSE: This randomized clinical trial is studying a personalized letter with Cancer Information Service support to see how well it works compared with a standard reminder letter in women scheduled for colposcopy after an abnormal Pap test.

Interventions

  • OTHER Usual care mailing intervention
  • OTHER CIS support mailing intervention

Trial Details

FieldValue
Enrollment Target 254 participants
Start Date 2006-10
Est. Completion 2008-11
Phase NA

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT00873288

The ClinicalTrials.gov registry entry for NCT00873288 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 254 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Usual care mailing intervention is the first listed.

NCT00873288 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00873288 about?

NCT00873288 is a clinical study titled "Activating Collaborative CIS Support Via Targeted Provider Mailing". RATIONALE: Receiving a reminder letter from their doctor with questions to ask the Cancer Information Service may be more effective than a standard reminder letter in helping patients who have had an abnormal Pap test keep their follow-up colposcopy appointment. PURPOSE: This randomized clinical tr...

What is the current status of trial NCT00873288?

This trial is currently completed. It is a NA study. The enrollment target is 254 participants. The study started on 2006-10. Estimated completion is 2008-11.

What interventions are being tested in trial NCT00873288?

The interventions under investigation include: Usual care mailing intervention (OTHER), CIS support mailing intervention (OTHER).

Who is sponsoring clinical trial NCT00873288?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.